Collagen Synthesis

Dr. Sarah Chen
PhD, Molecular Biology
Collagen is the most abundant protein in the human body, accounting for approximately 30% of total protein mass. In the skin, collagen comprises roughly 75% of the dry weight of the dermis and is the primary determinant of skin firmness, tensile strength, and structural integrity [1]. Understanding how collagen is synthesized — and how that process declines with age — is essential for understanding how regenerative treatments like PDRN work.
The 28 Collagen Types
The human genome encodes 28 distinct collagen types, designated by Roman numerals (I–XXVIII). In the skin, the most important are [1][2]:
- Type I collagen — The dominant collagen in adult skin (80–85% of dermal collagen). Forms thick, densely packed fiber bundles that provide tensile strength. Decline in type I collagen is the primary driver of skin laxity and wrinkle formation.
- Type III collagen — Comprises 10–15% of dermal collagen. Forms thinner, more flexible fibers often found alongside type I. More prevalent in young skin and wound healing — the type III to type I ratio decreases with age.
- Type IV collagen — A non-fibrillar collagen that forms the meshwork of the basement membrane (dermal-epidermal junction). Critical for anchoring the epidermis to the dermis.
- Type VII collagen — Forms anchoring fibrils that secure the basement membrane to the underlying dermis. Important for skin resilience and resistance to shearing forces.
The Collagen Biosynthetic Pathway
Collagen synthesis is a multi-step process that occurs both inside and outside the fibroblast cell [2]:
Step 1: Gene Transcription
Collagen production begins when fibroblasts receive stimulatory signals — growth factors (TGF-β, PDGF), mechanical tension from the extracellular matrix, or receptor-mediated signals such as those triggered by PDRN through the A2A receptor [4]. These signals activate transcription factors (including CREB, activated by the PDRN-A2A-cAMP-PKA cascade) that bind to collagen gene promoters, initiating transcription of procollagen mRNA.
Step 2: Translation and Hydroxylation
The mRNA is translated on ribosomes of the rough endoplasmic reticulum into procollagen alpha chains. As they are synthesized, specific proline and lysine residues are hydroxylated by prolyl hydroxylase and lysyl hydroxylase — enzymes that require vitamin C (ascorbic acid) as an essential cofactor, along with iron and α-ketoglutarate [2]. Without adequate vitamin C, these hydroxylation reactions fail, producing unstable collagen that cannot form proper triple helices. This is why vitamin C is a critical partner for any collagen-stimulating treatment, including PDRN.
Step 3: Triple Helix Assembly
Three hydroxylated procollagen alpha chains wind around each other to form the characteristic collagen triple helix (tropocollagen), stabilized by interchain hydrogen bonds between hydroxyproline residues. This assembly occurs in the endoplasmic reticulum and is quality-controlled — misfolded molecules are retained and degraded.
Step 4: Secretion and Processing
The procollagen triple helix is transported through the Golgi apparatus and secreted into the extracellular space. Once outside the cell, procollagen N- and C-proteinases cleave the extension peptides (propeptides) from both ends, converting procollagen into mature tropocollagen molecules.
Step 5: Fiber Assembly and Crosslinking
Tropocollagen molecules spontaneously self-assemble into collagen fibrils in a quarter-staggered arrangement. Lysyl oxidase then catalyzes covalent crosslinks between adjacent molecules, creating the strong, stable collagen fibers that give skin its tensile strength. This crosslinking step is the final maturation stage that determines the mechanical properties of the finished collagen.
How Collagen Declines with Age
After age 30, collagen production decreases by approximately 1–1.5% per year [3]. This decline involves multiple factors:
- Reduced fibroblast activity — Fibroblasts become less proliferative and less synthetically active. They produce less procollagen and respond less robustly to growth factor stimulation [5].
- Increased collagen degradation — Matrix metalloproteinases (MMPs), particularly MMP-1 (collagenase), increase with UV exposure and aging, actively breaking down existing collagen faster than it is replaced.
- Fibroblast collapse — In aged skin, the degraded collagen matrix can no longer provide the mechanical tension that fibroblasts need for normal function. Fibroblasts physically collapse, becoming smaller and less active — creating a self-reinforcing cycle of declining collagen production [5].
By age 80, the dermis may have lost 60–80% of its collagen content compared to young adult skin [3].
How PDRN Stimulates Collagen Synthesis
PDRN addresses multiple points in the collagen decline pathway [4]:
- Fibroblast proliferation — PDRN stimulates fibroblast cell division through A2A receptor-mediated cAMP elevation and nucleotide salvage pathway substrate supply, increasing the number of collagen-producing cells.
- Transcriptional activation — The PKA-CREB signaling cascade activated by PDRN upregulates collagen gene transcription, increasing procollagen mRNA production per cell.
- Anti-inflammatory protection — By suppressing NF-κB-driven MMP expression, PDRN reduces the enzymatic degradation of both newly synthesized and existing collagen.
- Angiogenic support — VEGF upregulation improves microcirculation, ensuring fibroblasts receive adequate oxygen, nutrients, and cofactors (including vitamin C delivered from the bloodstream) to sustain active collagen synthesis.
This multi-point intervention explains why PDRN produces measurable increases in dermal collagen density in clinical studies — it simultaneously increases production, reduces destruction, and supports the metabolic infrastructure needed for sustained collagen synthesis.
Key Takeaway
Collagen synthesis is a complex, multi-step process with multiple potential rate-limiting points. Effective strategies for increasing collagen production address the process at multiple levels: stimulating fibroblasts (PDRN, retinol, peptides), providing essential cofactors (vitamin C), protecting against degradation (antioxidants, anti-inflammatories), and maintaining the dermal environment (hydration, circulation). This is why combination approaches — such as PDRN + vitamin C + retinol — produce superior collagen outcomes compared to any single ingredient.
References
- [1]Ricard-Blum S. The Collagen Family. Cold Spring Harbor Perspectives in Biology. 2011;3(1):a004978. doi:10.1101/cshperspect.a004978 PMID:21421911
- [2]Shoulders MD, Raines RT. Collagen Structure and Stability. Annual Review of Biochemistry. 2009;78:929-958. doi:10.1146/annurev.biochem.77.032207.120833 PMID:19344236
- [3]Varani J, Dame MK, Rittie L, et al.. Decreased Collagen Production in Chronologically Aged Skin. American Journal of Pathology. 2006;168(6):1861-1868. doi:10.2353/ajpath.2006.051302
- [4]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Current Pharmaceutical Design. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [5]Fisher GJ, Varani J, Voorhees JJ. Looking Older: Fibroblast Collapse and Therapeutic Implications. Archives of Dermatology. 2008;144(5):666-672. doi:10.1001/archderm.144.5.666